Clinical Study Results
Most common adverse reactions during the study
MEDI0382 Placebo
Adverse reaction (out of 36 participants) (out of 15 participants)
Nausea 69.4% (25) 26.7% (4)
Low appetite 55.6% (20) 26.7% (4)
Vomiting 47.2% (17) 6.7% (1)
Headache 25.0% (9) 20.0% (3)
Diarrhea 22.2% (8) 20.0% (3)
How has this study helped people and researchers?
This study helped researchers learn more about the safety of MEDI0382 in participants
with obesity.
Researchers look at the results of many studies to decide which treatments work best and are
safest. This summary shows only the main results from this one study. Other studies may provide
new information or different results.
Other clinical studies with MEDI0382 are planned.
7